Cara Therapeutics, Inc. 4
4 · Cara Therapeutics, Inc. · Filed Jan 27, 2016
Insider Transaction Report
Form 4
Lewis Michael E
Chief Scientific Advisor
Transactions
- Sale
Common Stock
2016-01-26$10.93/sh−7,262$79,374→ 314,988 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2015.